TWD 32.3
(1.1%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 77.82 Million TWD | -25.2% |
2022 | 104.04 Million TWD | 92.51% |
2021 | 54.04 Million TWD | 56.32% |
2020 | 34.57 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 FY | 77.82 Million TWD | -25.2% |
2022 FY | 104.04 Million TWD | 92.51% |
2021 FY | 54.04 Million TWD | 56.32% |
2020 FY | 34.57 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
BIONET Corp. | 638.27 Million TWD | 87.806% |
DIVA Laboratories, Ltd. | 250.77 Million TWD | 68.964% |
Genetics Generation Advancement Corp. | 236.83 Million TWD | 67.137% |
Welgene Biotech Co.,Ltd. | 119.71 Million TWD | 34.989% |
Puriblood Medical Co., Ltd. | 6.52 Million TWD | -1093.147% |